We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.71B
AUM Growth
+$446M
Cap. Flow
+$341M
Cap. Flow %
19.94%
Top 10 Hldgs %
9.71%
Holding
550
New
109
Increased
194
Reduced
99
Closed
79

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$15.3M
2
HBAN icon
Huntington Bancshares
HBAN
+$13.6M
3
HRI icon
Herc Holdings
HRI
+$7.52M
4
HRL icon
Hormel Foods
HRL
+$7.32M
5
WAT icon
Waters Corp
WAT
+$7.24M

Sector Composition

Rank Sector Weight
1 Healthcare 18.39%
2 Consumer Discretionary 15.04%
3 Technology 12.88%
4 Industrials 11.93%
5 Energy 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
226
Vanda Pharmaceuticals
VNDA
$312M
$1.99M 0.12%
119,660
+3,900
+3% +$52.5K
CLNE icon
227
Clean Energy Fuels
CLNE
$447M
$1.9M 0.11%
+425,161
New +$1.62M
FHN icon
228
First Horizon
FHN
$12.1B
$1.9M 0.11%
+124,500
New +$1.84M
TVPT
229
DELISTED
Travelport Worldwide Limited
TVPT
$1.89M 0.11%
125,800
XLRN
230
DELISTED
Acceleron Pharma
XLRN
$1.89M 0.11%
52,101
BBG
231
DELISTED
Bill Barrett Corp
BBG
$1.87M 0.11%
336,300
+114,800
+52% +$683K
CDK
232
DELISTED
CDK Global, Inc.
CDK
$1.87M 0.11%
+32,542
New +$1.87M
RNG icon
233
RingCentral
RNG
$4.05B
$1.85M 0.11%
78,300
+59,100
+308% +$1.34M
BMY icon
234
Bristol-Myers Squibb
BMY
$127B
$1.85M 0.11%
34,330
-64,920
-65% -$4.17M
CHE icon
235
Chemed
CHE
$6.78B
$1.85M 0.11%
13,100
FUL icon
236
H.B. Fuller
FUL
$3B
$1.84M 0.11%
39,600
UNVR
237
DELISTED
Univar Solutions Inc.
UNVR
$1.84M 0.11%
84,070
+37,700
+81% +$740K
HQY icon
238
HealthEquity
HQY
$7.91B
$1.82M 0.11%
+48,200
New +$1.53M
CUDA
239
DELISTED
Barracuda Networks, Inc.
CUDA
$1.81M 0.11%
+70,900
New +$1.56M
GIB icon
240
CGI
GIB
$13.9B
$1.8M 0.11%
+37,700
New +$1.78M
WBT
241
DELISTED
Welbilt, Inc.
WBT
$1.77M 0.1%
+109,000
New +$1.86M
TNET icon
242
TriNet
TNET
$2.84B
$1.76M 0.1%
81,300
+16,642
+26% +$354K
CLDX icon
243
Celldex Therapeutics
CLDX
$2.77B
$1.73M 0.1%
28,553
-4,474
-14% -$279K
TECK icon
244
Teck Resources
TECK
$29.5B
$1.7M 0.1%
+94,500
New +$1.51M
BN icon
245
Brookfield
BN
$102B
$1.7M 0.1%
+135,092
New +$1.65M
EWT icon
246
iShares MSCI Taiwan ETF
EWT
$10B
$1.68M 0.1%
+53,500
New +$1.62M
HW
247
DELISTED
Headwaters Inc
HW
$1.68M 0.1%
99,100
+900
+0.9% +$16.6K
SLF icon
248
Sun Life Financial
SLF
$45.6B
$1.67M 0.1%
+51,228
New +$1.65M
HUBG icon
249
HUB Group
HUBG
$3.01B
$1.64M 0.1%
80,400
KRE icon
250
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$1.62M 0.09%
+38,300
New +$1.57M

Similar funds

PDT Partners's Q3 2016 Portfolio in Review

As of Q3 2016, PDT Partners held 550 positions worth $1.71B, up 35% from $1.26B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

PDT Partners deployed $341M of net new capital in Q3 2016, opening 109 new positions and adding to 194 existing holdings. Its largest new stake was Coty: 1,236,740 shares worth $29.1M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Huntington Bancshares, an estimated $13.6M trimmed.

  • PDT Partners's largest Q3 2016 buy was Coty: 1,236,740 shares worth $29.1M.
  • PDT Partners added most to Exelixis in Q3 2016, an estimated $30.3M increase.
  • PDT Partners's biggest Q3 2016 reduction was Huntington Bancshares, cutting an estimated $13.6M.
  • PDT Partners fully exited Regions Financial in Q3 2016, selling an estimated $15.3M.
  • PDT Partners's ten largest holdings make up 9.7% of its $1.71B portfolio in Q3 2016.
  • PDT Partners opened 109 new positions and closed 79 in Q3 2016.
  • PDT Partners's portfolio value rose 35% quarter-over-quarter to $1.71B.

Based on PDT Partners's 13F filing for Q3 2016, filed 14 Nov 2016.